Northern Trust
CELU icon

Northern Trust’s Celularity CELU Stock Holding History

Northern Trust’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Hold
44,163
– – ﹤0.01% 4348
2026
Q1 		$58.7K Hold
44,163
– – ﹤0.01% 4215
2025
Q4 		$49K Buy
44,163
+10,101
+30% +$18.1K ﹤0.01% 4283
2025
Q3 		$70.5K Hold
34,062
– – ﹤0.01% 4215
2025
Q2 		$66.8K Hold
34,062
– – ﹤0.01% 4185
2025
Q1 		$58.9K Hold
34,062
– – ﹤0.01% 4208
2024
Q4 		$70.8K Hold
34,062
– – ﹤0.01% 4212
2024
Q3 		$101K Hold
34,062
– – ﹤0.01% 4054
2024
Q2 		$107K Buy
34,062
+6,717
+25% +$23.3K ﹤0.01% 4039
2024
Q1 		$143K Buy
27,345
+13,520
+98% +$55.6K ﹤0.01% 3986
2023
Q4 		$34.2K Hold
13,825
– – ﹤0.01% 4299
2023
Q3 		$30.7K Hold
13,825
– – ﹤0.01% 4260
2023
Q2 		$73.6K Sell
13,825
-37,787
-73% -$242K ﹤0.01% 4117
2023
Q1 		$320K Sell
51,612
-3,339
-6% -$26.9K ﹤0.01% 3638
2022
Q4 		$709K Sell
54,951
-1,100
-2% -$20.3K ﹤0.01% 3383
2022
Q3 		$1.29M Buy
56,051
+45,123
+413% +$1.37M ﹤0.01% 3210
2022
Q2 		$372K Buy
+10,928
New +$888K ﹤0.01% 3644

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Northern Trust's CELU Position: Q2 2026 in Review

Northern Trust held its Celularity (CELU) position steady in Q2 2026 at 44,163 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4348.

Northern Trust first reported a position in CELU in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.29M in Q3 2022. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

  • Northern Trust held 44,163 shares of Celularity worth $26.4K as of Q2 2026.
  • Northern Trust left its Celularity share count unchanged in Q2 2026.
  • Celularity made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4348 holding.
  • Northern Trust first reported a position in Celularity in Q2 2022 and has held it in 17 quarters since.
  • Northern Trust's Celularity position peaked at $1.29M in Q3 2022.
  • 39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.